Zosano Pharma Reports First Quarter 2022 Financial Results
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...
Zosano Pharma Provides Corporate Update
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a...
Zosano Pharma Announces Reverse Stock Split Effective Today
ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022...